PharVision Advisers’s HF Sinclair DINO Stock Holding History

PharVision Advisers’s Portfolio DINO Stock Details DINO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,793	Closed	-$359K	–	254
2025 Q4	$359K	Buy	7,793 +3,238	+71%	+$167K	0.18%	171
2025 Q3	$238K	Buy	+4,555	New	+$216K	0.13%	365

Other funds holding DINO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's DINO Position: Q1 2026 in Review

PharVision Advisers sold out of HF Sinclair (DINO) in Q1 2026, closing a stake of 7,793 shares — an estimated $359K sold.

PharVision Advisers first reported a position in DINO in Q3 2025 and held it in 2 quarters. The position peaked at $359K in Q4 2025. 644 funds tracked by Wall St. Rank hold DINO as of Q1 2026.

PharVision Advisers reported no remaining HF Sinclair position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 7,793 HF Sinclair shares in Q1 2026, an estimated $359K.
PharVision Advisers first reported a position in HF Sinclair in Q3 2025 and held it in 2 quarters.
PharVision Advisers's HF Sinclair position peaked at $359K in Q4 2025.
644 funds tracked by Wall St. Rank held HF Sinclair as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.